Disparate techologies meet in NeXagen-Vestar merger
Disparate technologies meet in NeXagen-Vestar merger
Mergers can take many shapes, combining companies with overlapping technologies or those with disparate technologies and skills. Last week's deal between NeXagen Inc. and Vestar Corp. is one of the latter, melding NXGN's expertise in oligonucleotide drug discovery with VSTR's liposome drug delivery technology and infrastructure in manufacturing, clinical trials and marketing.
By bringing together two companies